Last reviewed · How we verify

NCT03946228: RESET-SLEEP

Reducing Sedentary Behavior to Improve Sleep: an Ancillary Study to the RESET BP Clinical Trial

Completed NA Last updated 7 July 2023
What this trial tests

NA trial testing Behavioral Intervention in Sleep in 176 participants. Completed in 30 December 2022.

Timeline
6 May 2019
Primary endpoint
30 December 2022
30 December 2022

Quick facts

Lead sponsorUniversity of Pittsburgh
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment176
Start date6 May 2019
Primary completion30 December 2022
Estimated completion30 December 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Pittsburgh

Who can join

Adults 21 to 65, any sex, with Sleep or Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Using a multi-method sleep assessment approach, the purpose of this study is to examine the bidirectional relationship between sleep and sedentary behavior in the context of a randomized trial investigating the impact of sedentary behavior reduction on blood pressure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Behavioral Intervention

Trials testing the same drug.

Other recruiting trials for Sleep

Currently open trials in the same condition.

Other University of Pittsburgh trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03946228.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing